medigraphic.com
SPANISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 606

<< Back Next >>

Rev Med Cos Cen 2013; 70 (606)

Tamizaje de cáncer colorrectal

Herrera MG, Gamboa MM, Durán BG, Monge CC
Full text How to cite this article

Language: Spanish
References: 15
Page: 273-280
PDF size: 184.72 Kb.


Key words:

Screening, colorectal cáncer, stool test, guaiac, stool DNA, flexible sigmoidoscopy, Colonoscopy.

ABSTRACT

Colorrectal cáncer is a serious pathology with a major impact in public health. CCR screening programs have demonstrated a reduction in incidence and mortality. There are several different modalities available for implementation on screening programs; each one with it’s own advantages and limitations. The objective of this article is to review the latest evidence for each screening tool so it can help us decide which would fit the best according to population’s resources and needs.


REFERENCES

  1. Barboza A, Vargas-Alvarado R y Muñoz-Leiva G. Ministerio de Salud, Dirección Vigilancia de la Salud, Unidad de Estadística- Registro Nacional de Tumores. Incidencia y Mortalidad del Cáncer en Costa Rica 1990-2003.

  2. Bo-in Lee et al. Korean Guidelines for Colorectal Cancer Screening and Polyp Detection. Clinical Endoscopy 2012;45:25-43

  3. Boltin D, Niv Y. Is there a place for Screening Flexible Sigmoidoscopy? Current colorectal Cancer Rep 2012;8:16-21

  4. Brink D, Barlow J, Bush K, Chaudhary N, Fareed M, Hayes R, Jafri I, Nair K, Retzer K, Rueter K. Institute for Clinical Systems Improvement. Colorectal Cancer Screening. http://bit. ly/Colorectal0512. Published May 2012

  5. Castells A. Cribado de Cáncer Colorrectal. Grastroenterol Hepatol 2012;35:68-73

  6. Chung Seng L, Leen R, O’Morain C, McNamara D. Screening for colorectal cancer: What fits best? Expert Review Gastroenterology Hepatolgy 2012;6(3), 301-312.

  7. Faivre J, Vincent Dancourt, Catherine Lejeune. Screening for colorectal cáncer with inmunochemical faecal occult blood tests. Dig Liver Dis 2012, http:// dx.doi.org/10.1016/j.dld.2012.07.004

  8. Greenwald B. The Stool DNA test: an emerging technology in colorectal cáncer screening. Gastroenteroly Nursing 2005;28(1):28-32

  9. Krishna C. Vemulapalli D. Guidelines for an Optimum Screening Colonoscopy. Curr Colorrectal Cancer Rep 2012;8:6-15.

  10. Levin B y col. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint guideline from the American Cancer Society, the U.S. Multi-Society Task Force on colorectal Cancer and the American College of Radiology. Gastroenterology 2008;134:1570-1595.

  11. Littlejohn C, Hilton S, Macfarlane G, Phull P. Systematic review and metaanalysis of the evidence for flexible sigmoidoscopy as a screening method for the prevention of colorectal cáncer. British journal of surgey 2012; 99:1488-1500

  12. Renée M, Melillo S, Marrone M. Fecal DNA testing for Colorectal Cancer Screening: the Colosure test. PLOS Currents Evidence on Genomic Tests. March, 2001. Edition 1 doi: 10.1371/currents.RRN1220

  13. Rodríguez Muñoz B. Técnicas Radiológicas en Cancer Colorrectal. Revista Medica de Costa Rica y Centroamerica 2008;583:169-173

  14. Schmoll H y col. ESMO consensus guidelines for management of patients with colon and rectal cáncer. A personalized approach to clinical decisión making. Annals of Oncology 2012;23:2479-2516.

  15. Sidney J. , Krabshuis J, Lambert R, O’Brien M, Fried M. Cascade Colorectal Cancer Screening guidelines A Global Conceptual Model. Journal of Clinical Gastroenterology 2011;45:297-300




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Cos Cen. 2013;70